UPDATE 1-Alnylam's gene silencing drug wins FDA approval

0
4
Peru president expects lithium, uranium mining laws passed in 6 months



Alnylam Pharmaceuticals Inc’s
drug for a rare hereditary disease won U.S. regulatory approval
on Friday, becoming the first approved treatment from a new
class of medicines that use gene silencing technology.

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here